Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
drug and medical device clinical development

News Release

Printer Friendly Version View printer-friendly version
<< Back
Medpace Holdings, Inc. to Report Third Quarter 2016 Financial Results on November 3, 2016

CINCINNATI--(BUSINESS WIRE)--Oct. 17, 2016-- Medpace Holdings Inc. (“Medpace”) today announced that it will report its third quarter 2016 financial results after the market close on Thursday, November 3, 2016, and will host a conference call the following morning, Friday, November 4, 2016, at 9:00 a.m. ET to discuss these results.

To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 2112859.

To access the conference call via webcast, visit the “Investors” section of Medpace’s website at The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.

A recording of the call will be available from 12:00 p.m. ET on Friday, November 4, 2016 until 11:00 a.m. ET on Friday, November 18, 2016. To hear this recording, dial 855-859-2056 (domestic) or 404-537-3406 (international) using the passcode 2112859.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,300 people across 35 countries.

Source: Medpace Holdings Inc.

Medpace Holdings, Inc.
Mary Kuramoto, 513-579-9911 x2523